NVG:NYE-Nuveen AMT Free Municipal Credit Income (USD)

FUND | Medical Distribution |

Last Closing

USD 13.31

Change

0.00 (0.00)%

Market Cap

N/A

Volume

0.36M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-22 )

Largest Industry Peers for Medical Distribution

Symbol Name Price(Change) Market Cap
COR Cencora Inc.

N/A

USD 44.41B
CAH Cardinal Health Inc

N/A

USD 26.96B
MCK McKesson Corporation

N/A

N/A
OMI Owens & Minor Inc

N/A

N/A

ETFs Containing NVG

MFLX First Trust Flexible Muni.. 0.81 % 0.00 %

N/A

USD 0.02B
PGAL 0.00 % 0.57 %

N/A

N/A
MCEF 0.00 % 0.75 %

N/A

N/A
XMPT 0.00 % 0.40 %

N/A

N/A
CD47:XETRA 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Distribution) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 12.61% 100% F 66% D+
Dividend Return 5.66% 100% F 85% B
Total Return 18.26% 100% F 74% C
Trailing 12 Months  
Capital Gain 23.35% 80% B- 68% D+
Dividend Return 7.06% 100% F 81% B-
Total Return 30.41% 100% F 74% C
Trailing 5 Years  
Capital Gain -20.06% 20% F 23% F
Dividend Return 22.28% 100% F 74% C
Total Return 2.22% 20% F 29% F
Average Annual (5 Year Horizon)  
Capital Gain -5.68% 20% F 14% F
Dividend Return -0.93% 20% F 20% F
Total Return 4.75% 100% F 79% B-
Risk Return Profile  
Volatility (Standard Deviation) 15.70% 100% F 62% D
Risk Adjusted Return -5.89% 20% F 21% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.